Home
About
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Science
Our Approach
The B Cell Advantage
Research
Pipeline
Investors & Media
Press Releases
News Articles
Contact
Careers
Home
About
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Science
Our Approach
The B Cell Advantage
Research
Pipeline
Investors & Media
Press Releases
News Articles
Contact
Careers
News
All
Press Releases
News Articles
/?php if (has_post_thumbnail()) { ?> /?php } ?>
Press Releases
November 01, 2016
Immusoft Finishes First Closing On Oversubscribed $3 Million Round
Related
News Articles
Genetic Engineering & Biotechnology News | October 17, 2024
Immusoft Reports Promising Early Data for Lead Candidate in MPS I
First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement therapy in Phase I trial
Read More
/?php if ( is_home()) { ?> /?php } ?>
News Articles
Endpoints News | October 15, 2024
First patient who received engineered B cell therapy sees early promise for MPS I
Read More
/?php if ( is_home()) { ?> /?php } ?>